Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis
Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis


Today, Illumina, Inc. (NASDAQ:ILMN) announced an agreement with the Belgian Genetic Centers to evaluate whole-genome sequencing (WGS) for the diagnosis of patients with intellectual disabilities

Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis
Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis


Today, Illumina, Inc. (NASDAQ:ILMN) announced an agreement with the Belgian Genetic Centers to evaluate whole-genome sequencing (WGS) for the diagnosis of patients with intellectual disabilities

Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand
Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand


Illumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of Southeast Asian Nations (ASEAN) leaders in

Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand
Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand


Illumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of Southeast Asian Nations (ASEAN) leaders in

Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand
Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand


Illumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of Southeast Asian Nations (ASEAN) leaders in

Illumina To Webcast Upcoming Investor Conference
Illumina To Webcast Upcoming Investor Conference


Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:




  • Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021

Illumina To Webcast Upcoming Investor Conference
Illumina To Webcast Upcoming Investor Conference


Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:




  • Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021

Illumina To Webcast Upcoming Investor Conference
Illumina To Webcast Upcoming Investor Conference


Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:




  • Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021

Humana Ranks #1 in J.D. Power Commercial Member Health Plan Study for Second Consecutive Year in Florida and Texas
Humana Ranks #1 in J.D. Power Commercial Member Health Plan Study for Second Consecutive Year in Florida and Texas


Leading health and well-being company Humana Inc. (NYSE: HUM) announced today that for the second consecutive year, it is ranked #1 in Florida and Texas in the J.D. Power ranking of Commercial

Dexcom Announces Upcoming Conference Presentation
Dexcom Announces Upcoming Conference Presentation


DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference:




  • Jereme Sylvain, Executive Vice President and Chief

Dexcom Announces Upcoming Conference Presentation
Dexcom Announces Upcoming Conference Presentation


DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference:




  • Jereme Sylvain, Executive Vice President and Chief

Simulations Plus to Participate in 18th Annual Craig-Hallum Institutional Investor Conference
Simulations Plus to Participate in 18th Annual Craig-Hallum Institutional Investor Conference


Simulations Plus, Inc. (Nasdaq: SLP), a premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that chief

Lantheus Receives U.S. FDA Approval of PYLARIFY® (piflufolastat F 18) Injection, the First and Only Commercially Available PSMA PET Imaging Agent for Prostate Cancer
Lantheus Receives U.S. FDA Approval of PYLARIFY® (piflufolastat F 18) Injection, the First and Only Commercially Available PSMA PET Imaging Agent for Prostate Cancer


Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence

NanoString to Webcast Presentation from the Jefferies Virtual Healthcare Conference
NanoString to Webcast Presentation from the Jefferies Virtual Healthcare Conference


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a

Acadia Healthcare to Participate in the Jefferies Virtual Healthcare Conference
Acadia Healthcare to Participate in the Jefferies Virtual Healthcare Conference


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the Jefferies Virtual Healthcare Conference, which takes place June 1 – June 4, 2021. There will

Agilent Reports Second-Quarter Fiscal Year 2021 Financial Results:
Agilent Reports Second-Quarter Fiscal Year 2021 Financial Results


Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.525 billion for the second quarter ended April 30, 2021, an increase of 23% compared to the second quarter of 2020 and up 19% on a

Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO) to Advance Clinical Research of Infectious Diseases
Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO) to Advance Clinical Research of Infectious Diseases


Waters Corporation (NYSE:WAT) today introduced a new RUO LC-MS test method to advance critical infectious disease research. Waters™ SARS-CoV-2 LC-MS Kit (RUO) uses an orthogonal analytical method

Quidel to Present Virtually at William Blair 41st Annual Growth Stock Conference
Quidel to Present Virtually at William Blair 41st Annual Growth Stock Conference


Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the

Health Canada Approves Quidel’s Sofia® SARS Antigen FIA Test for Screening of Asymptomatic Populations With Serial Testing
Health Canada Approves Quidel’s Sofia® SARS Antigen FIA Test for Screening of Asymptomatic Populations With Serial Testing


Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that its

Lantheus Holdings Announces Presentation Featuring 18F-DCFPyL PET/CT, its PSMA-Targeted Prostate Cancer Imaging Agent at the 2021 ASCO Annual Meeting
Lantheus Holdings Announces Presentation Featuring 18F-DCFPyL PET/CT, its PSMA-Targeted Prostate Cancer Imaging Agent at the 2021 ASCO Annual Meeting


Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence

Agilent to Present at Jefferies Virtual Healthcare Conference
Agilent to Present at Jefferies Virtual Healthcare Conference


Agilent Technologies Inc. (NYSE: A) today announced the company will participate in the Jefferies Virtual Healthcare Conference on June 1. Details are included below:



Jefferies Virtual Healthcare

Lantheus Holdings to Present at the Jefferies Virtual Healthcare Conference
Lantheus Holdings to Present at the Jefferies Virtual Healthcare Conference


Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions

NanoString to Webcast Presentation from the UBS Global Healthcare Conference
NanoString to Webcast Presentation from the UBS Global Healthcare Conference


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a

Agilent Announces Cash Dividend of 19.4 Cents per Share
Agilent Announces Cash Dividend of 19.4 Cents per Share


Agilent Technologies, Inc. (NYSE: A) today announced that a quarterly dividend of 19.4 cents per share of common stock will be paid on July 28, 2021, to all shareholders of record as of the close

Waters Corporation Celebrates the Life and Legacy of its Founder, Jim Waters
Waters Corporation Celebrates the Life and Legacy of its Founder, Jim Waters


Waters Corporation founder James L. Waters, a legendary inventor and pioneer in liquid chromatography whose work spurred a multi-billion-dollar industry and helped advance numerous scientific